The timing of complementary feeding in preterm infants and the effect on overweight: study protocol for a systematic

Karin M Vissers1, Edith J M Feskens2, Johannes B van Goudoever3

  • 1Department of Pediatrics, Hospital Gelderse Vallei, Ede, The Netherlands.

Systematic Reviews
|September 4, 2016
PubMed

Insights

This systematic review examines the impact of complementary feeding timing on overweight in preterm infants. It aims to clarify conflicting research and inform future feeding guidelines for this vulnerable population.

Area of Science:

  • Pediatrics
  • Nutrition Science
  • Public Health

Background:

  • Early complementary feeding is linked to childhood obesity in term infants.
  • Current guidelines from WHO and ESPGHAN for complementary feeding are not directly applicable to preterm infants.
  • Conflicting literature exists regarding the optimal timing of complementary feeding for preterm infants.

Purpose of the Study:

  • To systematically review the existing literature on the timing of complementary feeding in preterm infants.
  • To analyze the effect of the timing of complementary feeding on the risk of overweight (including obesity) in preterm infants.

Main Methods:

  • A comprehensive electronic systematic literature search will be conducted across multiple databases (Cochrane, PubMed, EMBASE, Web of Science, Scopus, CINAHL).
  • Randomized controlled trials (RCTs) will be the primary data source, with no time restrictions.
  • Independent review by three researchers, including risk of bias assessment, and use of Body Mass Index standard deviation score (BMI-SDS) for comparisons.

Main Results:

  • This section is to be populated upon completion of the systematic review and data analysis.

Conclusions:

  • This systematic review will consolidate current knowledge on complementary feeding timing in preterm infants and its association with overweight.
  • Findings will provide evidence to support the development of tailored guidelines for complementary feeding in preterm infants.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
267
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
329
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
343